Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2015 Sep 3;151(1):245–252. doi: 10.1016/j.jtcvs.2015.08.101

Table 1.

Baseline Microvessel Diameter and Percentage Preconstriction

Targets HCC LCI HCI p value
ADP Baseline Diameter μL 132.5 ± 41.5 114.3 ± 15.0 117.6 ± 35.8 0.62
ADP % Preconstriction 32.0 ± 10.4 35.1 ± 7.3 37.1 ± 6.8 0.56
SNP Baseline Diameter μL 151.3 ± 11.1 114.4 ± 28.5 116.4 ± 29.4 0.08
SNP % Preconstriction 34.5 ± 7.3 32.2 ± 8.8 35.7 ± 10.1 0.75

Values reported ± SD compared to HCC. One way analysis of variance performed to determine p value. Bonferroni multiple comparison tests were performed. HCC: High Cholesterol Control; LCI: Low Dose Calpain Inhibitor; HCI: High Dose Calpain Inhibitor